American Vanguard Reports Q1 2023 Results

Reaffirms Double-Digit Full-Year 2023 EBITDA Growth Despite Lower-Than-Expected Q1 Performance

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced financial results for the quarter ended March 31, 2023.

Q1 2023 Financial Performance – versus Q1 2022 (see table below):

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “During 2023, we expect to achieve higher adjusted EBITDA (between $84MM - $86MM) than in 2022, despite a first quarter setback arising from delays in restarting our supply chain, which is now back at capacity. After experiencing multiple delays, our China-based supplier was unable to deliver intermediates in sufficient quantities for our leading corn soil insecticide, Aztec®, until early 2023. As a result, we were only able to produce and sell about one-third of seasonal demand for that product. This, coupled with a glut of generic herbicides (not sold by the Company) in the distribution channel, led to lower sales of domestic crop products during the quarter. While our domestic non-crop and international businesses recorded higher sales, the decrease in sales of higher-margin US crop products led to lower overall profitability.”

In thousands except for per share data		March 31, 2023				March 31, 2022			Change
Net sales		$	124,885			$	149,593		$	(24,708	)
Net income		$	1,918			$	9,935		$	(8,017	)
EPS		$	0.07			$	0.33		$	(0.26	)
Adjusted EBITDA1		$	11,511			$	22,867		$	(11,356	)

Mr. Wintemute continued, “Even after taking into account a lower-than-expected first quarter, we still expect full year 2023 will be stronger than 2022. With extremely low inventories of our domestic crop products in the distribution channel, we anticipate higher sales of US crop products in the second half of 2023. Further, we expect to continue the positive trajectories of our non-crop and international businesses. While below our original targets, our revised 2023 targets nevertheless show better year-over-year performance, as you can see from the table below.”

Mr. Wintemute continued, “For the sake of clarity, starting with this fiscal year, we have adopted an accounting change which is more prevalent among public companies in our sector under which outbound freight is classified as an element of cost of goods, as opposed to an operating expense. For us, these costs have typically been in the range of 7-8% of net sales. Thus, under this revised approach, our gross margin percent would decrease by that amount, and operating expenses as a percent of sales would decrease commensurately. This change has no effect upon operating income, adjusted EBITDA, net income or earnings per share.”

2023 Performance Targets

Metric		2023 Range		2022 Actual		% Change
Net sales		$640MM - $652MM		$610MM		5 to 7%
Gross margin %		33 to 35%		34%		Similar
Opex as % of sales		25 to 27%		25%		Similar
Adjusted EBITDA		$84MM - $86MM		$73MM		14 to 18%
Net income		$32MM - $34MM		$27.5MM		17 to 25%

Mr. Wintemute concluded: “We look forward to giving you a more detailed presentation during our upcoming earnings call, including with respect to our 2025 growth targets.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, COO, David T. Johnson, CFO, Scott Hendrix, U.S. Crop SVP and Jim Thompson, Leader of the Green Solutions Initiative, will conduct a conference call focusing on the financial results and strategic themes at 5:00 pm ET on May 9, 2023. Interested parties may participate in the call by dialing 713-481-1320. Please call in 10 minutes before the scheduled start time and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamentals management, commercial and consumer pest control. American Vanguard is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share data) (Unaudited)
		March 31, 2023				December 31, 2022
Current assets:
Cash and cash equivalents		$	19,568			$	20,328
Receivables:
Trade, net of allowance for doubtful accounts of $5,692 and $5,136, respectively			166,120				156,492
Other			9,999				9,816
Total receivables, net			176,119				166,308
Inventories			219,080				184,190
Prepaid expenses			15,324				15,850
Income taxes receivable			4,879				1,891
Total current assets			434,970				388,567
Property, plant and equipment, net			71,538				70,912
Operating lease right-of-use assets			24,460				24,250
Intangible assets, net			181,909				184,664
Goodwill			47,366				47,010
Other assets			10,610				10,769
Deferred income tax assets, net			220				141
Total assets		$	771,073			$	726,313
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	74,887			$	69,000
Customer prepayments			70,338				110,597
Accrued program costs			71,379				60,743
Accrued expenses and other payables			38,038				20,982
Operating lease liabilities, current			5,367				5,279
Total current liabilities			260,009				266,601
Long-term debt, net			97,000				51,477
Operating lease liabilities, long term			19,614				19,492
Other liabilities, net of current installments			4,648				4,167
Deferred income tax liabilities, net			14,808				14,597
Total liabilities			396,079				356,334
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued			—				—
Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,463,829 shares at March 31, 2023 and 34,446,194 shares at December 31, 2022			3,446				3,444
Additional paid-in capital			107,591				105,634
Accumulated other comprehensive loss			(9,636	)			(12,182	)
Retained earnings			329,812				328,745
Less treasury stock at cost, 5,057,727 shares at March 31, 2023 and 5,029,892 shares at December 31, 2022			(56,219	)			(55,662	)
Total stockholders’ equity			374,994				369,979
Total liabilities and stockholders' equity		$	771,073			$	726,313

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited)
		For the three months ended March 31
		2023				2022
Net sales		$	124,885			$	149,593
Cost of sales			(86,348	)			(98,198	)
Gross profit			38,537				51,395
Operating expenses			(35,272	)			(36,646	)
Operating income			3,265				14,749
Change in fair value of an equity investment			(22	)			83
Interest expense, net			(1,686	)			(398	)
Income before provision for income taxes			1,557				14,434
Income tax benefit (expense)			361				(4,499	)
Net income		$	1,918			$	9,935
Earnings per common share—basic		$	0.07			$	0.33
Earnings per common share—assuming dilution		$	0.07			$	0.33
Weighted average shares outstanding—basic			28,367				29,677
Weighted average shares outstanding—assuming dilution			29,073				30,349

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES ANALYSIS OF SALES (Unaudited)
		For the three Months Ended March 31
		2023				2022				Change				% Change
Net sales:
U.S. crop		$	61,876			$	88,193			$	(26,317	)			-30	%
U.S. non-crop			13,899				13,396				503				4	%
Total U.S.			75,775				101,589				(25,814	)			-25	%
International			49,110				48,004				1,106				2	%
Total net sales:		$	124,885			$	149,593			$	(24,708	)			-17	%
Gross profit:
U.S. crop		$	20,622			$	33,993			$	(13,371	)			-39	%
U.S. non-crop			5,446				5,767				(321	)			-6	%
Total U.S.			26,068				39,760				(13,692	)			-34	%
International			12,469				11,635				834				7	%
Total gross profit:		$	38,537			$	51,395			$	(12,858	)			-25	%
Gross margin:
U.S. crop			33	%			39	%
U.S. non-crop			39	%			43	%
Total U.S.			34	%			39	%
International			25	%			24	%
Gross margin:			31	%			34	%

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited)
		For the three months ended March 31
		2023				2022
Cash flows from operating activities:
Net income		$	1,918			$	9,935
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of property, plant and equipment and intangible assets			5,539				5,230
Amortization of other long-term assets			714				1,173
Provision for bad debts			581				494
Fair value adjustment of contingent consideration			—				599
Stock-based compensation			1,474				1,563
Change in deferred income taxes			122				207
Change in liabilities for uncertain tax positions or unrecognized tax benefits			371				—
Other			94				2
Foreign currency transaction gains			(446	)			(261	)
Changes in assets and liabilities associated with operations:
Increase in net receivables			(8,779	)			(33,660	)
Increase in inventories			(33,731	)			(11,738	)
Decrease (increase) in prepaid expenses and other assets			600				(800	)
Change in income tax receivable/payable, net			(2,965	)			3,046
Increase in accounts payable			5,655				9,677
Decrease in customer prepayments			(22,759	)			(44,528	)
Increase in accrued program costs			10,660				24,601
(Decrease) increase in other payables and accrued expenses			(500	)			2,145
Net cash used in operating activities			(41,452	)			(32,315	)
Cash flows from investing activities:
Capital expenditures			(2,590	)			(3,294	)
Proceeds from disposal of property, plant and equipment			—				54
Acquisition of a product line			(703	)			—
Intangible assets			(15	)			(1,010	)
Net cash used in investing activities			(3,308	)			(4,250	)
Cash flows from financing activities:
Payments under line of credit agreement			(27,300	)			(12,000	)
Borrowings under line of credit agreement			72,000				58,000
Net receipt from the issuance of common stock under ESPP			480				436
Net receipt from the exercise of stock options			18				—
Receipt payment for tax withholding on stock-based compensation awards			(13	)			(2,174	)
Repurchase of common stock			(557	)			(6,219	)
Payment of cash dividends			(851	)			(594	)
Net cash provided by financing activities			43,777				37,449
Net (decrease) increase in cash and cash equivalents			(983	)			884
Effect of exchange rate changes on cash and cash equivalents			223				672
Cash and cash equivalents at beginning of period			20,328				16,285
Cash and cash equivalents at end of period		$	19,568			$	17,841

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO EBITDA (In thousands) (Unaudited)
		Three Months Ended March 31,
Reconciliation of Net Income to EBITDA		2023				2022
Net income, as reported		$	1,918			$	9,935
Provision for income taxes			(361	)			4,499
Interest expense, net			1,686				398
Proxy costs			541				—
Depreciation and amortization			6,253				6,472
Stock compensation			1,474				1,563
Adjusted EBITDA2		$	11,511			$	22,867

¹ Earnings before interest, taxes, depreciation, amortization and non-cash stock compensation. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. We provide these measures because we believe that they provide helpful comparisons to other companies in our industry and peer group. The items excluded from Adjusted EBITDA are detailed in the reconciliation attached to this news release, and reflect an elimination of taxes, interest, depreciation, amortization, the effects of equity compensation, and the proxy contest costs. Other companies (including the Company’s competitors) may define EBITDA differently.

² Earnings before interest, taxes, depreciation, amortization and non-cash stock compensation. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. We provide these measures because we believe that they provide helpful comparisons to other companies in our industry and peer group. The items excluded from Adjusted EBITDA are detailed in the reconciliation attached to this news release, and reflect an elimination of taxes, interest, depreciation, amortization, the effects of equity compensation, and the proxy contest costs. Other companies (including the Company’s competitors) may define EBITDA differently.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230509006219/en/

Company Contact:

American Vanguard Corporation

William A. Kuser, Director of Investor Relations

(949) 260-1200

williamk@amvac-chemical.com

Investor Representative

the Equity Group Inc.

www.theequitygroup.com

Lena Cati / 212-836-9611

Lcati@equityny.com

Source: American Vanguard Corporation